DRTSAlpha Tau Medical Ltd.

Healthcare
$13.16+238% 1Y

The financials

Alpha Tau Medical Ltd. by the numbers

Alpha Tau Medical Ltd. income statement, H2 2025 against the same quarter a year earlier
Income statementH2 2025H2 2023Change
Operating income−$23M−$19Mn/a
Net income−$24M−$12Mn/a
Diluted EPS−$0.28−$0.18n/a

Biotechnology

Ranks #152 of 194 by RyuScore

Compare peers
AVLN-4.6%
Avalyn Pharma Inc.
BCAX-3.2%
Bicara Therapeutics Inc.
GHRS-2.4%
GH Research PLC
SNDX-1.2%
Syndax Pharmaceuticals, Inc.
OMER-1.8%
Omeros
TYRA-2.1%
Tyra Biosciences, Inc.